USP18 and systemic lupus erythematosus: According to a guide to evaluating the utility of biomarkers based on AUC (28), IFI44, USP18, and RSAD2 can all be used as good indicators for differentiating SLE patients from healthy controls while NRIR was considered fair, but ISG15 had a poor capability.